Literature DB >> 20300923

[Radiotherapy of singular brain metastases].

Stefanie Windischbauer1, Felix Sedlmayer2.   

Abstract

Single cerebral metastases in malignant disease pose a particular therapeutic challenge. The options consist of surgical resection, stereotactic radiation, and total brain irradiation. No significant therapeutic advantage for any of these methods has as yet been demonstrated in the literature. We present the case of a young patient with a single brain metastasis of a sigmoidal carcinoma, in stable general condition. We present our therapeutic regimen and discuss the various pros and cons of the different therapies.

Entities:  

Mesh:

Year:  2010        PMID: 20300923     DOI: 10.1007/s10354-010-0754-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  13 in total

Review 1.  Multidisciplinary management of brain metastases.

Authors:  April F Eichler; Jay S Loeffler
Journal:  Oncologist       Date:  2007-07

2.  Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter.

Authors:  A Muacevic; F W Kreth; G A Horstmann; R Schmid-Elsaesser; B Wowra; H J Steiger; H J Reulen
Journal:  J Neurosurg       Date:  1999-07       Impact factor: 5.115

3.  Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases.

Authors:  A Schöggl; K Kitz; M Reddy; S Wolfsberger; B Schneider; K Dieckmann; K Ungersböck
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

4.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

5.  DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.

Authors:  Petra Feyer; Marie-Luise Sautter-Bihl; Wilfried Budach; Jürgen Dunst; Wulf Haase; Wolfgang Harms; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2010-01-26       Impact factor: 3.621

6.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

Authors:  Leo J Schouten; Joost Rutten; Hans A M Huveneers; Albert Twijnstra
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

7.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

8.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

Review 9.  A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases.

Authors:  Brian Patrick O'Neill; Nancy J Iturria; Michael J Link; Bruce E Pollock; Karla V Ballman; Judith R O'Fallon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-04-01       Impact factor: 7.038

10.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.

Authors:  Penny K Sneed; John H Suh; Steven J Goetsch; Seema N Sanghavi; Richard Chappell; John M Buatti; William F Regine; Eduardo Weltman; Vernon J King; John C Breneman; Paul W Sperduto; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.